Viewing Study NCT00890292

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:07 PM
Ignite Modification Date: 2026-02-03 @ 4:37 AM
Study NCT ID: NCT00890292
Status: COMPLETED
Last Update Posted: 2010-04-16
First Post: 2009-04-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of JNJ-31001074 in Pediatric Patients (12-17 Years) With Attention Deficit Hyperactivity Disorder (ADHD)
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Attention Deficit Hyperactivity Disorder View
None Attention Deficit Disorders With Hyperactivity View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Attention Deficit Hyperactivity Disorder View
None ADHD View
None JNJ-31001074 View